HOME >> BIOLOGY >> NEWS
Vascular disease and aging

rosclerosis.

The authors of a new study entitled, "Alterations in Gene Expression During Progressive Aging in Rat Thoracic Aorta," are Steven J. Miller and Joseph L. Unthank, Methodist Research Institute, Clarian Health, Indianapolis, IN and William C. Watson and Kimberly A. Kerr, Department of Surgery, Indiana University School, of Medicine, Indianapolis, IN. They will present their findings during the upcoming scientific conference, Understanding Renal and Cardiovascular Function Through Physiological Genomics, a meeting of the American Physiological Society (APS) (www.the-aps.org), being held October 1-4, 2003 at the Radisson Riverfront Hotel and Convention Center, Augusta, GA.

Methodology

In their earlier work, the researchers used oligonucleotide microarray analysis to investigate progressive age-mediated changes in gene expressions to demonstrate that vascular remodeling occurs in rat aorta with progressive aging. In the current study, thoracic aorta was harvested from 3-, 6-, 15-, and 28-month old F344xBNrats and total RNA was isolated. Microarray analysis was conducted using a standard protocol. Four biologic replicates were used for each age.

Results

The researchers found:

  • that the total number of genes with significant (p<0.01) changes in expression increased with progressive aging compared to 3-month old rats (11, 21, and 277 genes at 6, 15, and 28 months, respectively);
  • inflammatory-associated adhesion molecules ICAM-1 and VCAM-1 had significantly (p< 0.01) increased expression at 28 vs. 6 months (2.1x and 3.7x, respectively), as well as 28 vs. 15 months (1.6x and 2.0, respectively);
  • ICAM-1/VCAM-1 expression also increased at 15 vs. 6 months, but was not statistically significant; and
  • other functional groups of genes that were significantly altered with age at 28 vs. 6 months included increased
    '"/>


Contact: Donna Krupa
djkrupa1@aol.com
703-527-7357
American Physiological Society
30-Sep-2003


Page: 1 2 3

Related biology news :

1. Vascular access vital to pump up tissue engineering
2. Vascular Surgeons Test New Treatment For Abdominal Aneurysms
3. Study Links Viruses And Vascular Diseases
4. Schepens Eye Research Institute receives Roadmap grant to develop center for curing eye diseases
5. Alzheimers disease is not accelerated aging
6. New molecular link key to cellular proteins involved in cancer progression, other diseases
7. Wildlife Conservation Society hosts public symposium on human-wildlife diseases
8. University of Alberta researcher looks for clues to mysterious disease
9. Study explores gene transfer to modify underlying course of Alzheimers disease
10. Experimental drug shown to block mutant protein causing blood disease
11. Algal contact as a trigger for coral disease

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/2/2017)... 2, 2017 Who risk to be deprived ... the full report: https://www.reportbuyer.com/product/4313699/ WILL APPLE ... FIELD? Fingerprint sensors using capacitive technology represent a ... vendor Idex forecasts an increase of 360% of the ... of the fingerprint sensor market between 2014 and 2017 ...
(Date:2/28/2017)... News solutions for biometrics, bag drop and New ADA-compliant kiosk ... At PTE 2017 ... Materna will present its complete end-to-end passenger journey, from ... benefit for passengers. To accelerate the whole passenger handling process, ... to take passengers through the complete integrated process with a ...
(Date:2/24/2017)... -- EyeLock LLC, a leader of iris-based identity authentication ... solution on the latest Qualcomm® Snapdragon™ 835 mobile ... Congress 2017 (February 27 – March 2, ... Stand 3E10. The Snapdragon 835 ... combination of hardware, software and biometrics technologies ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... Mass. , March 23, 2017 /PRNewswire/ ... partner to global in vitro diagnostics manufacturers ... of the industry,s first multiplexed Inherited ... disease testing by next-generation sequencing (NGS). The ... were developed with input from industry experts ...
(Date:3/23/2017)... -- BioPharmX Corporation (NYSE MKT: BPMX), a specialty pharmaceutical ... reported financial results for the quarter and year ... update on the company,s clinical development efforts and ... pleased to report that last year was a ... Krammer. "We achieved key clinical milestones and attracted ...
(Date:3/23/2017)... March 23, 2017 Kineta, Inc., a ... novel therapies in immuno-oncology, today announced the discovery ... molecule compounds that activate interferon response factor 3 ... demonstrate immune-mediated tumor regression in a murine colon ... who demonstrated complete tumor regression to initial drug ...
(Date:3/23/2017)... ALBANY, New York , March 23, 2017 ... animal blood plasma products and derivatives market is fragmented due to the ... large players, such as Proliant, Thermo Fisher , and Sigma-Aldrich, ... clear leader, these three companies, collectively, held more than 76% of ... ...
Breaking Biology Technology:
Cached News: